CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed
Drug / intervention
suramindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00001381
NCT00001381Phase 1Completed
CompareCT.gov

A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder

National Cancer Institute (NCI)·interventional·Posted Dec 10, 2002·Updated Mar 4, 2008

In Brief

A Phase 1 clinical trial evaluating suramin for Bladder Neoplasms and Carcinoma, Transitional Cell. Completed, across 1 site.

Detailed Summary

Patients with superficial transitional cell carcinoma of the bladder will be treated with intravesical suramin in a phase I dose escalating study. The toxicity of suramin administered in this fashion will be evaluated.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBladder Neoplasms, Carcinoma, Transitional Cell
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 10, 2002
Enrollment StartMar 1, 1994
Study CompletionDec 1, 2000
TodayJul 2, 2026
Posted 23.6 years ago

Interventions

suramindrug